LOGIN  |  REGISTER
Terns Pharmaceuticals
Compass Therapeutics

Modivcare Releases 2023 Sustainability Report Highlighting Responsible Business Practices and Advancements in Environmental Management

May 23, 2024 | Last Trade: US$16.31 0.72 4.62

DENVER / May 23, 2024 / Business Wire / Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company released its 2023 Sustainability Report. The annual report provides an update regarding Modivcare’s sustainability framework, which is underpinned in four key areas: responsible business practices, member support, our team, and environmental management.

“Our 2023 Sustainability Report showcases our dedication to integrating sustainability in our business strategy while upholding responsible corporate citizenship,” said L. Heath Sampson, President and Chief Executive Officer of Modivcare. “We are further enhancing transparency and accountability for our sustainability initiatives, ensuring alignment with our corporate strategy and focus on the social determinants of health. Our team remains committed to providing high-quality supportive care services and enabling greater access to care for our members. Modivcare continues to foster an environment that celebrates the diversity and differences among our team members while promoting inclusivity. I am proud of the significant progress we have achieved in enhancing our disclosures as we continue to improve our sustainability efforts.”

Highlights from Modivcare’s 2023 Sustainability report:

  • Responsible Business Practices: We remain committed to upholding ethical business conduct across our operations while adhering to regulatory requirements, safeguarding the interests of our stakeholders and corporate reputation, and enhancing our risk management practices, all of which aligns with our corporate strategy.
  • Member Support: The support for our members underscores the social impact of our team and mission, while also highlighting our dedication to providing high-quality care and services to our clients and diverse members. We are committed to providing supportive care services and enabling greater access to care to vulnerable populations while helping to reduce costs and improve health outcomes.
  • Our Team: We take pride in showcasing our advancements in social responsibility, including our commitment to diversity, equity, inclusion, and belonging, as well as our contributions to community development, engagement, and philanthropic endeavors. Initiatives, such as employee resource groups, mentorship programs, and diversity training help create an inclusive environment for our team members.
  • Environmental Management: We are dedicated to environmental stewardship, driven by our initiatives to reduce carbon emissions, minimize waste generation, and promote resource conservation. During 2023, Modivcare’s Scope 1 and Scope 2 location-based and market-based greenhouse gas emissions decreased 12% and 11% year-over-year, respectively. 2023 was also the first year the Company disclosed Scope 3 emissions for certain categories.

Modivcare’s 2023 Sustainability Report can be found on the Company’s Investor Relations website on the governance documents page, which can be accessed by clicking this link.

About Modivcare

Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB